Form 13-F position report

IMMUNOGEN INC

Reported by Altium Capital Management LP

IMGN CUSIP 45253H101 Manager CIK 0001746382

Reported 280,000 shares, down 640,000 (69.6%) from the prior quarter.

Reported value -71.2%; share count -69.6% vs. the prior quarter.

Reduced
% of reported 13F value 0.5% This manager · Q2 2022
Shares 280,000 Quarter-end amount reported
Reported value $1,260,000 Fair value at quarter end
Consecutive quarters held 2 Through Q2 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2022-03-31 4379000
2022-06-30 1260000
2022-09-30 0
2023-06-30 9151950
2023-09-30 11505750
2023-12-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

6 quarters
Quarterly reported position history for IMMUNOGEN INC held by Altium Capital Management LP.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2023 Reduced 0 -725,000 (-100.0%) 0 $0 2024-02-14
Q3 2023 Added 725,000 +240,000 (49.5%) 6.0% $11,505,750 2023-11-14
Q2 2023 New 485,000 +485,000 (0.0%) 6.93% $9,151,950 2023-08-14
Q3 2022 Reduced 0 -280,000 (-100.0%) 0 $0 2022-11-14
Q2 2022 Reduced 280,000 -640,000 (-69.6%) 0.5% $1,260,000 2022-08-15
Q1 2022 New 920,000 +920,000 (0.0%) 1.47% $4,379,000 2022-05-16

Who else reported the position

224 managers reported IMMUNOGEN INC for Q2 2022.

Managers reporting IMMUNOGEN INC in Q2 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
RA CAPITAL MANAGEMENT L P Unchanged 21,741,458 0 2.61% $97,837,000 10 qtrs
STATE STREET CORPORATION Added 18,199,554 +4,492,165 < 0.01% $81,898,000 37 qtrs
BlackRock Inc Added 17,877,269 +1,444,336 < 0.01% $80,448,000 37 qtrs
VANGUARD GROUP INC Added 16,059,020 +580,504 < 0.01% $72,266,000 37 qtrs
DEERFIELD MANAGEMENT COMPANY L P SERIES C Added 15,020,490 +11,549,815 1.39% $67,592,000 2 qtrs
ADAGE CAPITAL PARTNERS GP L L C Unchanged 11,586,193 0 0.12% $52,138,000 7 qtrs
WELLINGTON MANAGEMENT GROUP LLP Reduced 10,717,085 -2,346,399 < 0.01% $48,227,000 20 qtrs
Redmile Group LLC Reduced 9,141,045 -76,900 1.57% $41,135,000 22 qtrs
MORGAN STANLEY Added 5,485,767 +241,147 < 0.01% $24,686,000 37 qtrs
Clearbridge Investments LLC Reduced 5,372,065 -130,778 0.02% $24,174,000 37 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2022
Filed
August 15, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
280,000
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.